相关实验视频

Updated: May 13, 2025

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

合成,抗结核评估和结构-活动关系的新SQ109类似物

Dijovani Batista Dos Reis¹, Emily Pacelli Moreira Linhares¹, Gabriel Dos Santos E Silva¹

¹LaSIMBio-Laboratório de Síntese de Moléculas Bioativas, Institute of Physics and Chemistry, Federal University of Itajubá, Itajubá, Brazil.

Archiv der Pharmazie

|April 16, 2025

概括

研究人员开发了新的功能化的SQ109脚手架,以对抗结核病 (TB). 这些化合物在体外显示出对Mycobacterium tuberculosis的有希望,可能改善治疗坚持性和克服耐药性.

科学领域:

药用化学医学化学
药物发现药物发现药物发现
微生物学微生物学

背景情况:

结核病 (TB) 治疗面临着长期药物治疗,副作用和耐药菌株的增加等挑战.
乙醇衍生的SQ109是一种有前途的第二代抗结核病药物.
功能化的SQ109支架可能会增强其治疗性质.

研究的目的:

为了合成新的功能化的SQ109脚手架.
评估它们在体外对Mycobacterium tuberculosis H37Rv.的疗效.
通过计算方法研究它们与膜蛋白的相互作用.

主要方法:

功能化SQ109衍生物的化学合成.
在体外对Mycobacterium结核病H37Rv.的敏感性测试.
分子对接和分子动力学模拟.

主要成果:

成功合成了新的功能化的SQ109脚手架.
在体外证明了对Mycobacterium tuberculosis H37Rv.的活性.
通过模拟,阐明了与膜蛋白的潜在相互作用.

结论:

功能化的SQ109支架代表了开发新的抗结核病药物的有希望的途径.
这些化合物可以提供更好的疗效,并克服现有的抵抗机制.
需要进一步的研究来探索它们的治疗潜力.

关键词:

结核病菌菌菌的结核病菌的结核病菌.在 SQ1099 中使用.分子对接的分子对接.分子动力学分子动力学结核病是一种肺结核病.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...